Evoluderm

The business operates on a model of providing quality, French-made products at accessible prices, positioning itself in the 'mass premium' market segment. It serves a global consumer base, with products available for the entire family, including face, body, hair, and baby care. Evoluderm has a significant international presence, distributing its products in over 100 countries across four continents. The company's revenue reached nearly EUR 40 million in 2025, having tripled in the preceding three years. Its business model is supported by a selectively integrated value chain that includes an in-house R&D laboratory, product development expertise, and logistics capabilities, which allows for the launch of over 30 new products annually.

Evoluderm's product line consists of approximately 250 items, including hydrating, cleansing, and nourishing solutions for skin and hair, with an emphasis on natural and vegan ingredients. A key aspect of their strategy is continuous product renewal, with about 30% of their references updated each year to meet new consumer desires. In February 2026, the company partnered with investment firm NextStage AM, securing a EUR 27 million growth capital investment to expand its physical and digital footprint and drive further product innovation.